Oryzon Genomics SA (XMAD:ORY)
European company
Share Price Chart
- Chart currently unavailable -
Market Info - ORY
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - ORY
- Market Cap€199.970m
- SymbolXMAD:ORY
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINES0167733015
Company Profile
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics.
Latest ORY news
Currently there for this company. Visit our news hub for other news .